熊云云,王拥军* 首都医科大学附属北京天坛医院神经病学中心;国家神经系统疾病临床医学研究中心;中国卒中学会临床研究中心(国际) *通讯作者 参考文献 1. Tong D, Reeves MJ, Hernandez AF, et al. Times from symptom onset to hospital arrival in the Get with the Guidelines--Stroke Program 2002 to 2009: temporal trends and implications. Stroke 2012;43:1912-7. 2. Thomalla G, Simonsen CZ, Boutitie F, et al. MRI-guided thrombolysis for stroke with unknown time of onset. N Engl J Med 2018;379:611-22. 3. Ma H, Campbell BCV, Parsons MW, et al. Thrombolysis guided by perfusion imaging up to 9 hours after onset of stroke. N Engl J Med 2019;380:1795-803. 4. Nogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med 2018;378:11-21. 5. Albers GW, Marks MP, Kemp S, et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med 2018;378:708-18. 6. Menon BK, Buck BH, Singh N, et al. Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial. Lancet 2022;400:161-9. 7. Wang Y, Li S, Pan Y, et al. Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferiority trial. Lancet 2023;401:645-54. 8. GF KM, Ford I, Wardlaw JM, et al. Tenecteplase versus alteplase for acute stroke within 4.5h of onset: the second alteplase-tenecteplase trial evaluation for stroke thrombolysis (ATTEST-2). 15th World Stroke Congress, 10-12 October 2023, Toronto, Canada. International Journal of Stroke. 2023;18(3_suppl):3-420. 9. Albers GW, Jumaa M, Purdon B, et al. Tenecteplase for stroke at 4.5 to 24 hours with perfusion-imaging selection. N Engl J Med 2024; 390:701-11. 10. Campbell BCV, Mitchell PJ, Churilov L, et al. Tenecteplase versus Alteplase before thrombectomy for ischemic stroke. N Engl J Med 2018;378:1573-82. 述评作者 版权信息 |
|